The oncogenic properties of the HMG-I gene family

Cancer Research

Volumn 60, Issue 15, 2000, Pages 4256-4261

  Wood, L J ^a   Maher, J F ^a   Bunton, T E ^a   Resar, L M S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXY 3 METHYLGLUTARIC ACID; BINDING PROTEIN;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; MALIGNANT TRANSFORMATION; METASTASIS; NONHUMAN; NUDE MOUSE; ONCOGENE; ONCOGENE MYC; PRIORITY JOURNAL; RAT;

ANIMALS; CELL ADHESION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION; HIGH MOBILITY GROUP PROTEINS; HMGA1A PROTEIN; HUMANS; MICE; MICE, NUDE; NEOPLASM PROTEINS; ONCOGENES; RATS; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 0033881018     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (85)

1. Structural features of the HMG chromosomal proteins and their genes
2. High-mobility-group chromosomal proteins: Architectural components that facilitate chromatin function
3. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins
4. Chromosomal localization of the murine gene and 2 related sequences encoding high-mobility group I and Y proteins
5. The chromosomal high mobility group protein HMG-I(Y): Complete murine cDNA sequence, genomic structure, and tissue expression
6. Organization, inducible expression and chromosomal localization of the human HMG-I(Y) nonhistone protein gene
7. High-mobility-group proteins and cancer : An emerging link
8. Comparison of multiple forms of the high mobility group I proteins in rodent and human cells: Identification of the human high mobility group I-C protein
9. cDNA cloning of the HMG-C phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes
10. Expression and cDNA cloning of human HMGI-C phosphoprotein
11. Genomic structure and expression of the murine Hmgi-c gene
12. The high mobility group I-C gene (HMGI-C): Polymorphism and genetic localization
13. The high mobility group protein HMGI(Y) is required for NF-κB-dependent virus induction of the human IFN-β gene
14. The high mobility group protein HMG I(Y) is an essential structural component of viral-inducible enhancer complex
15. Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements
16. Virus induction of human IFN-β gene expression requires the assembly of an enhanceosome
17. Reversal of intrinsic DNA bends in the IFNβ gene enhancer by transcription factors and the architectural protein HMG I(Y)
18. Multivalent DNA-binding properties of the HMG-I proteins
19. SAR-dependent mobilization of histone H1 by HMG-I/Y in vitro: HMG-I/Y is enriched in H1-depleted chromatin
20. SARs are cis DNA elements of chromosome dynamics: Synthesis of a SAR repressor protein
21. In vivo analysis of scaffold-associated regions in Drosophila: A synthetic high-affinity SAR binding protein suppresses position effect variegation
22. The A-T-DNA-binding domain of mammalian high mobility group I chromosomal proteins: A novel peptide motif for recognizing DNA structure
23. A mammalian high mobility group protein recognizes any stretch of six A-T base pairs in duplex DNA
24. Short peptide derived from HMG-I/Y proteins bind specifically to the minor groove of DNA
25. The HMG-I(Y) AT-hook peptide motif confers DNA-binding specificity to a structures chimeric protein
26. On the presence of two new high mobility group-like proteins in HeLa S3 cells
27. Changes in nuclear proteins on transformation of rat epithelial thyroid cells by a murine sarcoma retrovirus
28. The expression of the high mobility group HMGI(Y) protein correlates with the malignant phenotype of human thyroid neoplasias
29. Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells
30. Elevated levels of a specific class of nuclear phosphoproteins in cells transformed with v-ras and v-mos oncogenes and by co-transfection with c-myc and polyoma middle T genes
31. Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures
32. Analysis of multiple forms of the HMGI proteins in rodent and human cells: Identification of the third protein. HMGI-C in human cells
33. High-mobility-group (HMG) proteins and histone H 1 subtypes expression in normal and tumor tissues of mouse
34. Growth-factor induced delayed early response genes
35. Elevated high mobility group I(Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells
36. Identification of high mobility group I(Y) as potential progression marker for prostate cancer
37. Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization
38. A retrospective study of high mobility group I(Y) as progressive marker for prostate cancer determined by in situ hybridization
39. A mammalian delayed-early response gene encodes HNP36, a novel, conserved nucleolar protein
40. Function of the c-Myc oncogenic transcription factor
41. S. HMG-I/Y: A new c-Myc target gene and potential oncogene
42. Recurrent rearrangements in the high mobility group protein gene. HMGI-C, in benign mesenchymal tumours
43. Disruption of the architectural factor HMG-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains
44. From chromosomal aberrations to the high mobility group protein gene family: Evidence for a common denominator in benign solid tumor development
45. A fibroadenoma with a t(4;12)(q27;q15) affecting the HMGI-C gene, a member of the high mobility group protein family
46. HMGI-C rearrangements as the molecular basis for the majority of pulmonary chondroid hamartomas: A survey of 30 tumors
47. Translocations in solid tumors
48. Rearrangements of the high mobility group protein family genes and the molecular genetic origin of the uterine leiomyomas and endometrial polyps
49. Transcriptional activation of HMGI-C in three pulmonary hamartomas each with a der(14)t(12;14) as the sole cytogenetic abnormality
50. An endometrial poly with a rearrangement of HMGI-C underlying a complex cytogenetic rearrangement involving chromosomes 2 and 12
51. Expression of HMGI-C, a member of the high mobility group protein family, in a subset of breast cancers: Relationship to histologic grade
52. Fusion transcripts between the HMGIC gene and RTVL-H-related sequences in mesenchymal tumors without cytogenetic aberrations
53. Expression of the reciprocal hybrid transcripts of HMGIC and FHIT in a pleomorphic adenoma of the parotid gland
54. HMGIC expressed in a uterine leiomyoma with a deletion of the long arm of chromosome 7 along with a 12q14-15 rearrangement but not in tumors showing del(7) as the sole cytogenetic abnormality
55. Chromosomal translocations in benign tumors: The HMGI proteins
56. Identification of NFIB as recurrent translocation partner gene of HMGIC in pleomorphic adenomas
57. Cloning of a breakpoint cluster region on chromosome 14 in uterine leiomyoma
58. Amplification and expression of the HMGIC gene in a benign endometrial polyp
59. Expression of reciprocal fusion transcripts of the HMGIC and LPP genes in parosteal lipoma
60. Genetic basis of uterine leiomyoma: Involvement of high mobility group protein genes
61. Is HMGIC rearranged due to cryptic paracentric inversion of 12q in karyotypically normal uterine leiomyomas?
62. Intron 3 of HMGIC is the most frequent target of chromosomal aberrations in human tumors and has been conserved basically for a t least 30 million years
63. Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts
64. The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis
65. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C
66. Neoplastic transformation by the human gene N-myc
67. c-Myc transactivation of LDH-A: Implications for tumor metabolism and growth
68. Identification of putative c-Myc-responsive genes: Characterization of rcl, a novel growth-related gene
69. Pathogenesis of Burkitt lymphoma: Expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphocytes
70. Opposite regulation of gene transcription and cell proliferation by c-Myc and Max
71. Fibroblast lines expressing activated c-myc oncogenes are tumorigenic in nude mice and syngeneic animals
72. Chromosomal translocation in human cancer
73. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-I gene, related to Drosophila trithorax, to the AF-4 gene
74. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias
75. Molecular characterization of MAR, a multiple aberration region on human chromosome segment 12q14-q15 implicated in various solid tumors
76. A striking similarity in the organization of the E-selectin and β interferon gene promoters
77. Cooperativity between two NFκB complexes, mediated by high-mobility-group protein I(Y), is essential for cytokine-induced expression of the E-selectin promoter
78. Induction of high mobility group-I(Y) protein by endotoxin and interleukin-1β in vascular smooth muscle cells: Role in activation of inducible nitric oxide synthetase
79. A poly(dA-dT) upstream activation sequence binds high-mobility group I protein and contributes to lymphotoxin (tumor necrosis factor-β) gene regulation
80. Regulation of cell-type-specific interleukin-2 receptor α-chain gene expression: Potential role of physical interactions between Elf-I, HMG-I(Y), and NF-κB family proteins
81. Multiple closely-linked NFAT/octamer and HMG I(Y) binding sites are pat of the interleukin-4 promoter
82. Sequence-specific binding of HMG-I(Y) to the proximal promoter of the gp91-phox gene
83. Sequence-specific binding of HMG-I(Y) to the proximal promoter of the gp91-phox gene (published erratum)
84. The non-histone chromosomal protein HMG-I(Y) contributes to repression of the immunoglobulin heavy chain germ-line epsilon RNA promoter
85. An HMG I(Y)-containing repressor coupled and supercoiled DNA topology are critical for long-range enhancer-dependent transcription in vitro